A Phase II Trial of Avelumab or Hydroxychloroquine with or without Palbociclib to Eliminate Dormant Breast Cancer (“PALAVY”)

Status: Open to Accrual

Learn more:

• https://clinicaltrials.gov/study/NCT04841148

Study Contact: studies@hoosiercancer.org; (317) 921-2050.